2Dorr RT, Alberts DS,Stone A. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. Cancer Treat Rep, 1985,69:431 - 437.
3Bertelli G, Dini D, FOMO GB, et al. Hyaluronidase as an antidote to extravasation to vinca alkaloids. Cancer Bes Clin Oncol, 1994,120:505 - 506.
4Door RT, Soble M, Alberts DS. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse. Cancer Chemother pharmacol, 1988,22:299 - 302.
5Vandeweyer F, Deraemaecker R. Early surgical suction and washout for treatment of cytotoxic drug extravasation, Acta Chlr Belg, 2000,100:37-38.
6Bertelli G. Prevention and management of extravasation of cytotoxic drugs. Drug Saf, 1995,12:245 - 255.
8Dorr RT, Pordal MS, Koenig LM, et aL High doxorubicin tissue levels in a patients experiencing extravasation during a four day infusion.Cancer, 1989,64 : 2462 - 2464.
9Herrington JD, Figueroa JA. Severe necrosis due to paclitaxel extravasation. Pharmacotherapy, 1997,17 : 163 - 165.
10Door RT. Antidotes to vesicant chemotherapy extravasation. Blood Rev, 1990,4:41-60.
